Thorsten Waloschek: 3D-Bioprinted Placentas Could Predict and Prevent Preeclampsia
Thorsten Waloschek, CEO at NeoPredics AG, shared a post on LinkedIn:
“Scientists in Sydney have 3D-bioprinted miniature placentas – a breakthrough that could transform how we understand pregnancy complications like preeclampsia.
Until now, studying the early placenta has been almost impossible. By the time a baby is born, the organ looks very different from its first-trimester state, and animal models don’t capture the unique biology of humans. Bioprinting changes that. Researchers can now grow organoids that closely mimic early placental tissue, expose them to stressors linked to preeclampsia, and even test potential therapies.
It is still early days, but this feels like a leap toward a future where complications in pregnancy could be predicted, prevented, or treated before they put lives at risk. Advances like this remind us how much innovation in bioengineering can ripple far beyond the lab, reshaping the health of generations to come.”
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now